Sleep spindles in early course schizophrenia and first-degree relatives
Sleep spindles in early course schizophrenia and first-degree relatives
批准号:
9139499
负责人:
MATCHERI S. KESHAVAN
金额:
$62.48万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-09-07 至 2020-05-31
关键词:
AdolescenceAgeAntipsychotic AgentsAreaBiological MarkersChronicCognitionCognitive deficitsCognitive remediationContralateralDevelopmentEarly InterventionEszopicloneFamilyFirst Degree RelativeFunctional disorderGeneral HospitalsHealthHospitalsImpaired cognitionImpairmentIndividualIsraelLaboratoriesLearningLinkLiteratureMassachusettsMeasuresMediatingMedical centerModelingMotorNeurobiologyParticipantPatientsPilot ProjectsPopulationPredispositionPreventionPsychopathologyPsychotic DisordersRecording of previous eventsRecruitment ActivityRelative RisksResistanceRiskSamplingSchizophreniaSleepSleep disturbancesSocioeconomic StatusStagingSymptomsTask PerformancesTimeWorkbasecognitive functiondensityeffective therapyemerging adultendophenotypeexecutive functionexperiencefunctional disabilityfunctional outcomeshigh riskimprovedmemory consolidationmental health centerneural correlateneuroimagingnon rapid eye movementnovelrelating to nervous systemsextrait
中文摘要
描述(由申请人提供):一个新兴的文献表明,睡眠纺锤波介导睡眠依赖性记忆巩固和认知功能更普遍。与此同时,最近的几项研究表明,睡眠纺锤波在SZ中显着减少。认知缺陷是精神分裂症(SZ)的一个核心特征,是严重功能障碍的基础,缺乏有效的治疗方法。我们实验室以前的工作将睡眠纺锤体缺陷与SZ的睡眠依赖性记忆巩固、智商和执行功能受损联系起来,并表明它是可治疗的。但目前尚不清楚这种睡眠纺锤体缺陷是否存在于SZ的早期,以及它是否反映了其病理生理学和家族性疾病风险的核心障碍。在这项研究中,我们将研究睡眠纺锤波,它们与记忆巩固和认知的关系,以及它们在早期SZ患者中的神经基础。(E-SZ; n=30),并伴有其他精神病(E-NSZ; n=30),在SZ家族性高风险SZ患者的年轻亲属中(FHR; n=60)和在年龄、性别和父母社会经济地位匹配的健康对照(HC)受试者中。我们假设:(i)E-SZ和FHR,而不是E-NSZ,与HC相比,将显示出减少的纺锤波;(ii)纺锤波的数量和密度将与所有组的睡眠依赖性记忆巩固、智商和整体认知功能相关,并且睡眠纺锤波不足将与E-SZ和FHR的阳性和前驱症状相关;和(iii)在运动任务学习后的睡眠期间,HC和E-NSZ,而不是E-SZ或FHR参与者,将显示增加的纺锤体密度和连贯性,特别是在运动网络中。我们还预测,减少纺锤体密度将与丘脑皮质功能和结构连接的减少。我们的假设,如果得到证实,将有助于建立睡眠梭形缺陷作为(i)SZ的内在表型,可以作为家族风险的生物标志物(用于研究SZ的病因学),和(ii)认知障碍的新治疗的目标。
英文摘要
DESCRIPTION (provided by applicant): A burgeoning literature suggests that sleep spindles mediate sleep-dependent memory consolidation and cognitive function more generally. At the same time, several recent studies show that sleep spindles are dramatically reduced in SZ. Cognitive deficits are a core feature of schizophrenia (SZ) that underlie significant functional disability and effective treatments are lacking. Previous work from our laboratories links the sleep spindle deficit with an impairment of sleep-dependent memory consolidation, IQ and executive function in SZ, and suggests that it is treatable. But it is unclear whether this sleep spindle deficit is present early in SZ, and whether it reflects a core disturbance central to its pathophysiology and familial risk of illness. In this study, we will examine sleep spindles, their relationship to memory consolidation and cognition more generally, and their neural underpinnings in early-course patients both with SZ (E-SZ; n=30), and with other psychoses (E-NSZ; n=30), in young relatives of SZ patients at familial high risk for SZ (FHR; n=60) and in healthy comparison (HC) subjects matched for age, sex and parental socioeconomic status. We hypothesize (i) that E-SZ and FHR, but not E-NSZ, will show reduced spindles compared with HC; (ii) that spindle number and density will correlate with sleep-dependent memory consolidation, IQ and overall cognitive function in all groups, and that deficient sleep spindles will correlate with positive and prodromal symptoms in E-SZ and FHR; and (iii) that during the sleep that follows motor task learning, HC and E-NSZ, but not E-SZ or FHR participants, will show increased spindle density and coherence, specifically in the motor network. We also predict that reduced spindle density will correlate with a reduction in thalamocortical functional and structural connectivity. Our hypotheses, if confirmed, will help establish the sleep spindle deficit as (i) an endophenotype of SZ, which can serve as a biomarker of familial risk (for studying the etiopathology of SZ), and (ii) a target for novel treatments of cognitive impairment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS)
-
批准号:10683233
-
项目类别:
-
资助金额:$25.91万
-
财政年份:2022
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
4/5: Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (CLOZAPINE)
-
批准号:10396433
-
项目类别:
-
资助金额:$27.51万
-
财政年份:2021
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
4/5: Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (CLOZAPINE)
-
批准号:10613507
-
项目类别:
-
资助金额:$27.5万
-
财政年份:2021
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Longitudinal trajectories in treated and untreated schizophrenia
-
批准号:10306962
-
项目类别:
-
资助金额:$64.17万
-
财政年份:2021
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Characterizing cognition across the lifespan in untreated psychosis in China
-
批准号:9403816
-
项目类别:
-
资助金额:$60.26万
-
财政年份:2015
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Sleep spindles in early course schizophrenia and first-degree relatives
-
批准号:9702857
-
项目类别:
-
资助金额:$55.46万
-
财政年份:2015
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Adaptation of Cognitive Enhancement Therapy for persons at Psychosis High Risk
-
批准号:8976169
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2014
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
4/6 Psychosis and Affective Research Domains and Intermediate Phenotypes (PARDIP)
-
批准号:8506547
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2013
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
4/6 Psychosis and Affective Research Domains and Intermediate Phenotypes (PARDIP)
-
批准号:8706965
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2013
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Brain Imaging, Cognitive Enhancement and Early Schizophrenia
-
批准号:8453355
-
项目类别:
-
资助金额:$60.08万
-
财政年份:2012
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Brain Imaging, Cognitive Enhancement and Early Schizophrenia
-
批准号:8644914
-
项目类别:
-
资助金额:$60.76万
-
财政年份:2012
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Brain Imaging, Cognitive Enhancement and Early Schizophrenia
-
批准号:8236770
-
项目类别:
-
资助金额:$67.46万
-
财政年份:2012
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Brain Imaging, Cognitive Enhancement and Early Schizophrenia
-
批准号:8831006
-
项目类别:
-
资助金额:$60.16万
-
财政年份:2012
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
CORE--CLINICAL
-
批准号:7553455
-
项目类别:
-
资助金额:$23.25万
-
财政年份:2007
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
4/5 Bipolar-Schizophrenia Network for Intermediate Phenotypes
-
批准号:9293368
-
项目类别:
-
资助金额:$56.47万
-
财政年份:2007
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Bipolar & Schizophrenia Consortium for Parsing Intermediate Phenotypes
-
批准号:7668419
-
项目类别:
-
资助金额:$80.15万
-
财政年份:2007
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Bipolar & Schizophrenia Consortium for Parsing Intermediate Phenotypes
-
批准号:7917305
-
项目类别:
-
资助金额:$77.04万
-
财政年份:2007
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Bipolar & Schizophrenia Consortium for Parsing Intermediate Phenotypes
-
批准号:7384973
-
项目类别:
-
资助金额:$80.95万
-
财政年份:2007
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
EFFECT OF QUETIAPINE ON DELTA SLEEP DEFICITS IN SCHIZOPHRENIA
-
批准号:7201198
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2005
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
BRAIN CIRCUITRY AND COGNITION IN PSYCHOSIS
-
批准号:7201211
-
项目类别:
-
资助金额:$2.3万
-
财政年份:2005
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: